Rasdegafusp alfa Uses, Dosage, Side Effects and more
Rasdegafusp alfa is under investigation in clinical trial NCT03206047 (Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer).
Trade Name | Rasdegafusp alfa |
Generic | Rasdegafusp alfa |
Rasdegafusp alfa Other Names | Rasdegafusp alfa |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |